New radiation pulses aim to tame tough pancreatic tumors

NCT ID NCT07269626

Recruiting now Disease control Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 18, 2026 · Updated 19 times

Summary

This study tests a new way to deliver radiation called PULSAR, which gives short, powerful pulses of proton therapy every few weeks, adapting to changes in the tumor. It is for people with pancreatic cancer that has not spread widely. The goal is to improve local tumor control while reducing side effects, and to keep patients on their regular chemotherapy with fewer breaks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Samsung Medical Center
RECRUITING

Seoul, Select Province/State, 06351, South Korea

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA OLIGOMETASTATIC PANCREATIC DUCTAL ADENOCARCINOMA